Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 3 (2007), Issue 8 (August)

1. Determinants of Virologic and Immunologic Outcome in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) Study.
   J Acquir Immune Defic Syndr. [Abstract] [Full-text]
2. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
   Liver Transpl, 13(8): 1100-8. [Abstract] [Full-text]
3. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
   Lancet, 370(9585): 407-13. [Abstract] [Full-text]
4. Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia.
   Dig Dis Sci, 52(9): 2410-7. [Abstract] [Full-text]
5. Virological failure and subsequent resistance profiles in individuals exposed to atazanavir.
   AIDS, 21(13): 1826-8. [Abstract] [Full-text]
6. The cost-effectiveness of the new protocol reflecting rapid virologic response to peginterferon alpha-2b and ribavirin for chronic hepatitis C.
   Eur J Gastroenterol Hepatol, 19(9): 733-9. [Abstract] [Full-text]
7. Evaluating the cost of sustained virologic response in naïve chronic hepatitis C patients treated à la carte.
   Aliment Pharmacol Ther, 26(5): 705-16. [Abstract] [Full-text]
8. Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure.
   AIDS Patient Care STDS, 21(8): 544-50. [Abstract] [Full-text]
9. TORO: Ninety-Six-Week Virologic and Immunologic Response and Safety Evaluation of Enfuvirtide with an Optimized Background of Antiretrovirals.
   AIDS Patient Care STDS, 21(8): 533-43. [Abstract] [Full-text]
10. Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients.
    Antimicrob Agents Chemother, 51(9): 3067-74. [Abstract] [Full-text]
11. Virological fitness of HIV in patients with resistance to enfuvirtide.
    AIDS, 21(14): 1974-7. [Abstract] [Full-text]
12. Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.
    AIDS, 21(14): 1972-4. [Abstract] [Full-text]
13. Baseline genotype as a predictor of virological failure to emtricitabine or Stavudine in combination with Didanosine and efavirenz.
    AIDS Res Hum Retroviruses, 23(8): 988-95. [Abstract] [Full-text]
14. Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase.
    J Acquir Immune Defic Syndr, 45(5): 494-500. [Abstract] [Full-text]
15. Impaired CCR7 expression on plasmacytoid dendritic cells of HIV-infected children and adolescents with immunologic and virologic failure.
    J Acquir Immune Defic Syndr, 45(5): 501-7. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.